Morgan Stanley’s Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share VHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1
Closed 7997
2022
Q2
$0 Hold
1
﹤0.01% 8099
2022
Q1
$0 Sell
1
-5,575
-100% -$714 ﹤0.01% 8224
2021
Q4
$1K Sell
5,576
-1,001
-15% -$272 ﹤0.01% 7914
2021
Q3
$2K Hold
6,577
﹤0.01% 7703
2021
Q2
$2K Hold
6,577
﹤0.01% 7556
2021
Q1
$3K Buy
+6,577
New +$3.52K ﹤0.01% 7233

Other funds holding VHAQ.WS

Morgan Stanley's VHAQ.WS Position: Q3 2022 in Review

Morgan Stanley sold out of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) in Q3 2022, closing a stake of 1 share.

Morgan Stanley first reported a position in VHAQ.WS in Q1 2021 and held it in 6 quarters. The position peaked at $3K in Q1 2021. 31 funds tracked by Wall St. Rank hold VHAQ.WS as of Q3 2022.

  • Morgan Stanley reported no remaining Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position as of Q3 2022 after selling out during the quarter.
  • Morgan Stanley sold 1 Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share share in Q3 2022.
  • Morgan Stanley first reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in Q1 2021 and held it in 6 quarters.
  • Morgan Stanley's Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position peaked at $3K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share as of Q3 2022.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.